Volume 165, Issue 5, Pages (May 2001)

Slides:

Advertisements

Similar presentations

CYFRA 21-1 as a Prognostic and Predictive Marker in Advanced Non–Small-Cell Lung Cancer in a Prospective Trial: CALGB Martin J. Edelman, MD, Lydia.

Advertisements

Volume 187, Issue 6, Pages (June 2012)

Fig. 2. Kaplan-Meier curves for survival in each breast cancer molecular subtype. Radiologic assessment in triple-negative breast cancer (A), HER2-positive.

Immunohistochemical analysis of epidermal growth factor receptor family members in stage I non-small cell lung cancer Wu-Wei Lai, MD, Fen-Fen Chen, MD,

Volume 58, Issue 3, Pages (September 2010)

Volume 155, Issue 3, Pages (March 1996)

MP60-03 PROSTATE CANCER IN THE ELDERLY

Outcomes of Primary Squamous Cell Carcinoma of Major Salivary Glands Treated by Surgery With or Without Postoperative Radiotherapy Lina Wang, MD, Hao.

Volume 105, Issue 3, Pages (March 1994)

Vascular endothelial growth factor expression in non-small-cell lung cancer: Prognostic significance in squamous cell carcinoma Hideyuki Imoto, MD, Toshihiro.

Volume 195, Issue 5, Pages (May 2016)

Volume 58, Issue 2, Pages (August 2010)

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

Volume 61, Issue 5, Pages (May 2012)

Bladder Lymphoma The Journal of Urology

Volume 186, Issue 5, Pages (November 2011)

Volume 51, Issue 5, Pages (May 2007)

Volume 61, Issue 4, Pages (April 2012)

Volume 63, Issue 1, Pages (January 2013)

Bladder Cancer: A Major Public Health Issue

Pseudohyperplastic Adenocarcinoma of the Prostate

Prognostic Value of Low Blood Glucose at the Presentation of E

Volume 199, Issue 4, Pages (April 2018)

Prognostic Significance of TAZ Expression in Resected Non-Small Cell Lung Cancer Mian Xie, MD, PhD, Li Zhang, MD, Chao-Sheng He, MD, Jin-Hui Hou, MD,

Prognostic Significance of C-Reactive Protein and Smoking in Patients with Advanced Non-small Cell Lung Cancer Treated with First-Line Palliative Chemotherapy

Volume 185, Issue 2, Pages (February 2011)

Volume 56, Issue 6, Pages (December 2009)

Expression of programmed death receptor ligand 1 in melanoma may indicate tumor progression and poor patient survival Junna Oba, MD, PhD, Takeshi Nakahara,

Design and Multiseries Validation of a Web-Based Gene Expression Assay for Predicting Breast Cancer Recurrence and Patient Survival Ryan K. Van Laar

Volume 43, Issue 2, Pages (February 2003)

APLCC ORAL ABSTRACT SESSIONS - MONDAY, NOVEMBER 26

Bronchioloalveolar Carcinoma (Lepidic Growth) Component Is a More Useful Prognostic Factor than Lymph Node Metastasis Yoichi Anami, MD, Tatsuo Iijima,

Volume 47, Issue 1, Pages (January 2005)

Volume 53, Issue 1, Pages (January 2008)

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Adjuvant Chemotherapy with 5-Fluorouracil and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell Carcinoma Jeeyun Lee, MD, Kyoung-Eun.

Epidermal Growth Factor Receptor Is a Prognosis Predictor in Patients With Esophageal Squamous Cell Carcinoma Wencheng Zhang, MD, Hongxia Zhu, MD, Xiao.

The Presence of Mutations in Epidermal Growth Factor Receptor Gene Is Not a Prognostic Factor for Long-Term Outcome after Surgical Resection of Non–Small-Cell.

Three Versus 4 Daily Exchanges and Residual Kidney Function Decline in Incident CAPD Patients: A Randomized Controlled Trial Hao Yan, MD, Wei Fang, MD,

Tumor Angiogenesis as a Prognostic Marker in Operable Non–Small Cell Lung Cancer Katsuhiko Matsuyama, Yukio Chiba, Masato Sasaki, Hirokazu Tanaka, Ryusuke.

Volume 71, Issue 5, Pages (May 2017)

Factors predictive of prognosis after esophagectomy for squamous cell cancer Houhuai Li, MD, PhD, Qingzhen Zhang, Lin Xu, MD, Yijiang Chen, Yongxiang.

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer Robert E. Merritt, MD, Chuong D. Hoang, MD,

Kavitha K. Reddy Journal of Investigative Dermatology

Predictors of the Risk of Mortality in Neurofibromatosis 2

Mariano Garcı́a-Yuste, MD, José M

Survival of Women With Cancer in Palliative Care: Use of the Palliative Prognostic Score in a Population of Brazilian Women Cláudia Naylor, MD, Lúcia.

Use of the Palliative Performance Scale (PPS) for End-of-Life Prognostication in a Palliative Medicine Consultation Service Francis Lau, PhD, Vincent.

Prognostic Impact of Comorbidity in Patients with Bladder Cancer

Jeffrey Bradley, MD, Issam El Naqa, PhD Journal of Thoracic Oncology

miR-210 Is a Prognostic Marker in Clear Cell Renal Cell Carcinoma

Squamous cell carcinomas of the skin responsive to erlotinib: 5 cases

Tumor-Infiltrating Foxp3+ Regulatory T Cells are Correlated with Cyclooxygenase-2 Expression and are Associated with Recurrence in Resected Non-small.

High MET Gene Copy Number Leads to Shorter Survival in Patients with Non-small Cell Lung Cancer Heounjeong Go, MD, Yoon Kyung Jeon, MD, PhD, Hyo Jin.

A propensity analysis comparing definitive chemo-radiotherapy for muscle-invasive squamous cell carcinoma of the bladder vs. urothelial carcinoma of the.

Erratum Journal of Thoracic Oncology

Icotinib in Patients with Pretreated Advanced Esophageal Squamous Cell Carcinoma with EGFR Overexpression or EGFR Gene Amplification: A Single-Arm, Multicenter.

Immunohistochemical analysis of epidermal growth factor receptor family members in stage I non-small cell lung cancer Wu-Wei Lai, MD, Fen-Fen Chen, MD,

Volume 52, Issue 4, Pages (October 2007)

Is the B12/CRP Index More Accurate Than You at Predicting Life Expectancy in Advanced Cancer Patients? Filipa Tavares, MD Journal of Pain and Symptom.

Michael J. Germain, MD, Sara N. Davison, MD, Alvin H. Moss, MD

American Journal of Kidney Diseases

Carcinoma of the esophagus: Prognostic significance of histologic type

Comparison of Low-Dose Gentamicin With Minocycline as Catheter Lock Solutions in the Prevention of Catheter-Related Bacteremia Uday S. Nori, MD, Anup.

Surgical outcomes after cardiac surgery in liver transplant recipients

A Randomized Controlled Trial of Coiled Versus Straight Swan-Neck Tenckhoff Catheters in Peritoneal Dialysis Patients David W. Johnson, PhD, Jennifer.

Trends in Life Expectancy After Spinal Cord Injury

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

Long-Term Results of Sleeve Lobectomy in the Management of Non–Small Cell Lung Carcinoma and Low-Grade Neoplasms Robert E. Merritt, MD, Douglas J. Mathisen,

Node-Negative Non-small Cell Lung Cancer: Pathological Staging and Survival in 1765 Consecutive Cases Benjamin M. Robinson, BSc, MBBS, Catherine Kennedy,

Presentation transcript:

Volume 165, Issue 5, Pages 1481-1487 (May 2001) BILHARZIAL RELATED, ORGAN CONFINED, MUSCLE INVASIVE BLADDER CANCER: PROGNOSTIC VALUE OF APOPTOSIS MARKERS, PROLIFERATION MARKERS, p53, E-CADHERIN, EPIDERMAL GROWTH FACTOR RECEPTOR AND c- erbB-2 ANDREA HAITEL, BERND POSCH, MAHMOUD EL-BAZ, ALAA A. MOKHTAR, MARTIN SUSANI, MOHAMED A. GHONEIM, MICHAEL MARBERGER The Journal of Urology Volume 165, Issue 5, Pages 1481-1487 (May 2001) DOI: 10.1016/S0022-5347(05)66332-X Copyright © 2001 American Urological Association, Inc. Terms and Conditions

Fig. 1 Kaplan-Meier disease-free survival curves for transitional cell carcinoma (TCC) versus squamous cell carcinoma (SCC) (log-rank test p = 0.0001). The Journal of Urology 2001 165, 1481-1487DOI: (10.1016/S0022-5347(05)66332-X) Copyright © 2001 American Urological Association, Inc. Terms and Conditions

Fig. 2 Kaplan-Meier disease-free survival curves for Bak negative versus Bak positive in squamous cell carcinoma (log-rank test p = 0.039). The Journal of Urology 2001 165, 1481-1487DOI: (10.1016/S0022-5347(05)66332-X) Copyright © 2001 American Urological Association, Inc. Terms and Conditions

Fig. 3 Kaplan-Meier disease-free survival curves for Bak negative versus Bak positive in transitional cell carcinoma (log-rank test p = 0.040). The Journal of Urology 2001 165, 1481-1487DOI: (10.1016/S0022-5347(05)66332-X) Copyright © 2001 American Urological Association, Inc. Terms and Conditions

Fig. 4 Kaplan-Meier disease-free survival curves for p53 40% or less versus p53 greater than 40% in squamous cell carcinoma (log-rank test p = 0.00001). The Journal of Urology 2001 165, 1481-1487DOI: (10.1016/S0022-5347(05)66332-X) Copyright © 2001 American Urological Association, Inc. Terms and Conditions

Fig. 5 Kaplan-Meier disease-free survival curves for p53 40% or less versus p53 greater than 40% in transitional cell carcinoma (log rank test p = 0.0058). The Journal of Urology 2001 165, 1481-1487DOI: (10.1016/S0022-5347(05)66332-X) Copyright © 2001 American Urological Association, Inc. Terms and Conditions

Fig. 6 Kaplan-Meier disease-free survival curves for p53 40% or less versus p53 greater than 40% in squamous cell carcinoma (log rank test p = 0.00001). The Journal of Urology 2001 165, 1481-1487DOI: (10.1016/S0022-5347(05)66332-X) Copyright © 2001 American Urological Association, Inc. Terms and Conditions

Fig. 7 Kaplan-Meier disease free-survival curves. A, grades 1 and 2 versus 3 in squamous cell carcinoma (log rank test p = 0.021). B, c-erbB-2 negative versus c-erbB-2 positive in transitional cell carcinoma (log rank test p = 0.036). C, Bcl-x negative versus Bcl-x positive in transitional cell carcinoma (log rank test p = 0.015). D, MIB-1 30% or less versus MIB-1 greater than 30% in transitional cell carcinoma (log rank test p = 0.034). The Journal of Urology 2001 165, 1481-1487DOI: (10.1016/S0022-5347(05)66332-X) Copyright © 2001 American Urological Association, Inc. Terms and Conditions